Depemokimab, a Long-Acting (Twice-Yearly) Monoclonal Antibody for Adults and Adolescents With Severe Eosinophilic Asthma Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

publication date

  • July 2025